Clinical Trials Directory

Trials / Completed

CompletedNCT05246540

Evaluation of PET/CT of Cephalic Arteries for the Diagnosis of Giant Cell Arteritis

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Giant cell arteritis (GCA) is the most common vasculitis in adults. The diagnosis of GCA is evoked by the association of clinical signs and biological anomalies (inflammatory syndrome) in patients over 50 years of age. On the other hand, starting a treatment implies being certain of the diagnosis which requires performing a temporal artery biopsy under local anesthesia. This examination is therefore an invasive procedure for patients whose sensitivity is not optimal. This is why imaging techniques (echo-Doppler or MRI of the temporal arteries) have been developed to look for signs of vasculitis without the need to perform a biopsy. However, these examinations lack sensitivity (=falsely concluding the absence of GCA) and specificity (=falsely concluding the presence of GCA). Recently, advances in imaging, and in particular positron emission tomography (PET), have made it possible to visualize the cephalic arteries, including the temporal artery. The aim of this study is therefore to evaluate the sensitivity and specificity of PET of the cephalic arteries for the diagnosis of GCA and to compare them with those of echo-Doppler and MRI of the temporal arteries.

Conditions

Interventions

TypeNameDescription
OTHERData collectionData collection

Timeline

Start date
2020-01-01
Primary completion
2020-12-01
Completion
2021-12-01
First posted
2022-02-18
Last updated
2026-01-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05246540. Inclusion in this directory is not an endorsement.